Research Progress of Long Non-coding RNA as Regulator in Pathogenesis of Cardiovascular Disease
Author:
Affiliation:

1.Medical College of University of South China, Hengyang, Hunan 421001, China;2.Sun Yat-sen Cardiovascular Hospital, Shenzhen, Guangdong 518000, China)

Clc Number:

R5

  • Article
  • | |
  • Metrics
  • |
  • Reference [29]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    With the development of molecular biology technology in recent years, cardiovascular disease research entered the era of genetic testing. An increasing number of studies shows that, lncRNA not only has close relationship with cardiovascular disease, but also plays a key role in cardiovascular disease of the regulation mechanism. This review focuses on the association between lncRNA and cardiovascular disease.

    Reference
    [1] Wapinski O, Chang HY.Long noncoding RNAs and human disease.Trends Cell Biol, 1,1 (6):354-361.
    [2] 胡春松, 吴清华, 胡大一.中国心血管现状:挑战与对策.中华高血压杂志, 5,3 (7):625-626.
    [3] Caley DP, Pink RC, Trujillano D, et al.Long noncoding RNAs, chromatin, and development.ScientificWorld-Journal, 0,0:90-102.
    [4] ENCODE Project Consortium, Birney E, Stamatoyannopoulos JA, et al.Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project.Nature, 7,7 (7146):799-816.
    [5] Nagano T, Fraser P.No-nonsense functions for long noncoding RNAs.Cell, 1,5 (2):178-181.
    [6] Ma L, Bajic VB, Zhang Z.On the classification of long non-coding RNAs.RNA Biol, 3,0 (6):925-933.
    [7] Mercer TR, Dinger ME, Mattick JS.Long non-coding RNAs:insights into functions.Nat Rev Genet, 9,0 (3):155-159.
    [8] 连晓清, 王连生.长链非编码RNA的功能及与心血管病的研究进展.国际遗传学杂志, 2,5 (5):295-299.
    [9] Guttman M, Rinn JL.Modular regulatory principles of large non-coding RNAs.Nature, 2,2 (7385):339-346.
    [10] Uchida S, Dimmeler S.Long noncoding RNAs in cardiovascular diseases.Circ Res, 5,6 (4):737-750.
    [11] Thum T, Condorelli G.Long noncoding RNAs and microRNAs in cardiovascular pathophysiology.Circ Res, 5,6 (4):751-762.
    [12] Gao W, Wang ZM, Zhu M, et al.Altered long noncoding RNA expression profiles in the myocardium of rats with ischemic heart failure.J Cardiovasc Med (Hagerstown), 5,6 (7):473-479.
    [13] Rose BA, Force T, Wang Y.Mitogen-activated protein kinase signaling in the heart:angels versus demons in a heart-breaking tale.Physiol Rev, 0,0 (4):1 507-546.
    [14] Portbury AL, Ronnebaum SM, Zungu M, et al.Back to your heart:ubiquitin proteasome system-regulated signal transduction.J Mol Cell Cardiol, 2,2 (3):526-537.
    [15] Liu H, Song G, Zhou L, et al.Compared analysis of LncRNA expression profiling in pdk1 gene knockout mice at two time points.Cell Physiol Biochem, 3,2 (5):1 497-508.
    [16] Kumarswamy R, Bauters C, Volkmann I, et al.Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure.Circ Res, 4,4 (10):1 569-575.
    [17] Archer K, Broskova Z, Bayoumi AS, et al.Long non-coding RNAs as master regulators in cardiovascular diseases.Int J Mol Sci, 5,6 (10):23 651-667.
    [18] Helgadottir A, Thorleifsson G, Magnusson KP, et al.The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm.Nat Genet, 8,0 (2):217-224.
    [19] Pasmant E, Sabbagh A, Vidaud M, et al.ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS.FASEB J, 1,5 (2):444-448.
    [20] Foroud T, Koller DL, Lai D, et al.Genome-wide association study of intracranial aneurysms confirms role of Anril and SOX17 in disease risk.Stroke, 2,3 (11):2 846-852.
    [21] Liu Q, Huang J, Zhou N, et al.LncRNA loc285194 is a p53-regulated tumor suppressor.Nucleic Acids Res, 3,1 (9):4 976-987.
    [22] Wang S, Zhang X, Yuan Y, et al.BRG1 expression is increased in thoracic aortic aneurysms and regulates proliferation and apoptosis of vascular smooth muscle cells through the long non-coding RNA HIF1A-AS1 in vitro.Eur J Cardiothorac Surg, 5,7 (3):439-446.
    [23] Zhao Y, Feng G, Wang Y, et al.Regulation of apoptosis by long non-coding RNA HIF1A-AS1 in VSMCs:implications for TAA pathogenesis.Int J Clin Exp Pathol, 4,7 (11):7 643-652.
    [24] He Q, Tan J, Yu B, et al.Long noncoding RNA HIF1A-AS1A reduces apoptosis of vascular smooth muscle cells:implications for the pathogenesis of thoracoabdominal aorta aneurysm.Pharmazie, 5,0 (5):310-315.
    [25] Wu G, Cai J, Han Y, et al.LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity.Circulation, 4,0 (17):1 452-465.
    [26] Hu YW, Zhao JY, Li SF, et al.RP5-833A20.1/miR-382-5p/NFIA-dependent signal transduction pathway contributes to the regulation of cholesterol homeostasis and inflammatory reaction.Arterioscler Thromb Vasc Biol, 5,5 (1):87-101.
    [27] Hu YW, Yang JY, Ma X, et al.A lincRNA-DYNLRB2-2/GPR119/GLP-1R/ABCA1-dependent signal transduction pathway is essential for the regulation of cholesterol homeostasis.J Lipid Res, 4,5 (4):681-697.
    [28] Gao W, Zhu M, Wang H, et al.Association of polymorphisms in long non-coding RNA H19 with coronary artery disease risk in a Chinese population.Mutat Res, 5,2:15-22.
    [29] Yang Y, Cai Y, Wu G, et al.Plasma long non-coding RNA, CoroMarker, a novel biomarker for diagnosis of coronary artery disease.Clin Sci (Lond), 5,9 (8):675-685.
    Cited by
Get Citation

LU Yao-Xing, YANG Jian-An, LIU Yin-He. Research Progress of Long Non-coding RNA as Regulator in Pathogenesis of Cardiovascular Disease[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2016,24(5):537-540.

Copy
Share
Article Metrics
  • Abstract:1155
  • PDF: 343
  • HTML: 0
  • Cited by: 0
History
  • Received:January 15,2016
  • Revised:March 24,2016
  • Online: June 30,2016
Article QR Code